Correlation Between Genovate Biotechnology and Feature Integration

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genovate Biotechnology and Feature Integration at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genovate Biotechnology and Feature Integration into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genovate Biotechnology Co and Feature Integration Technology, you can compare the effects of market volatilities on Genovate Biotechnology and Feature Integration and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovate Biotechnology with a short position of Feature Integration. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovate Biotechnology and Feature Integration.

Diversification Opportunities for Genovate Biotechnology and Feature Integration

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Genovate and Feature is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Genovate Biotechnology Co and Feature Integration Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Feature Integration and Genovate Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovate Biotechnology Co are associated (or correlated) with Feature Integration. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Feature Integration has no effect on the direction of Genovate Biotechnology i.e., Genovate Biotechnology and Feature Integration go up and down completely randomly.

Pair Corralation between Genovate Biotechnology and Feature Integration

Assuming the 90 days trading horizon Genovate Biotechnology Co is expected to generate 2.39 times more return on investment than Feature Integration. However, Genovate Biotechnology is 2.39 times more volatile than Feature Integration Technology. It trades about 0.02 of its potential returns per unit of risk. Feature Integration Technology is currently generating about 0.04 per unit of risk. If you would invest  2,805  in Genovate Biotechnology Co on October 30, 2024 and sell it today you would lose (415.00) from holding Genovate Biotechnology Co or give up 14.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Genovate Biotechnology Co  vs.  Feature Integration Technology

 Performance 
       Timeline  
Genovate Biotechnology 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Genovate Biotechnology Co are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Genovate Biotechnology may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Feature Integration 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Feature Integration Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Feature Integration is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Genovate Biotechnology and Feature Integration Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genovate Biotechnology and Feature Integration

The main advantage of trading using opposite Genovate Biotechnology and Feature Integration positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovate Biotechnology position performs unexpectedly, Feature Integration can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Feature Integration will offset losses from the drop in Feature Integration's long position.
The idea behind Genovate Biotechnology Co and Feature Integration Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
FinTech Suite
Use AI to screen and filter profitable investment opportunities